Tetrahydrofolate: role in periconceptional supplementation and prenatal care

• Kareva Elena N.
• Zorina Larisa A.
• Sudnitsina Maria V.

Abstract

Keywords:folates, folic acid, pregnant women, newborns, developmental pathology, pathology of pregnant women

References

1. Blom H.J., Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis. 2011; 34 (1): 75-81.

2. Rosenauerova-Ostra A., Hilgertova J., Sonka J. Urinary formiminoglu-tamate in man. Normal values related to sex and age. Effects of low calorie intake and alcohol consumption. Clin Chim Acta. 1976; 73 (1): 39-43.

3. Blount B.C., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA. 1997; 94 (7): 3290-5.

4. Fenech M. Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity. Mutat Res (Fundamental and Molecular Mechanisms of Mutagenesis). 2012; 733 (1-2): 21-33.

5. Hoffbrand A.V., Jackson B.F. Correction of the DNA synthesis defect in vitamin B12 deficiency by tetrahydrofolate: evidence in favour of the methyl-folate trap hypothesis as the cause of megaloblastic anaemia in vitamin B12 deficiency. Br J Haematol. 1993; 83 (4): 643-7.

6. Palmer A.M., Kamynina E., Field M.S., Stover P.J. Folate rescues vitamin B12 depletion-induced inhibition of nuclear thymidylate biosynthesis and genome instability. Proc Natl Acad Sci USA. 2017; 114 (20): E4095-102.

7. Pustotina O.A. Achievements and risks of folate use outside and during pregnancy. Meditsinskiy sovet [Medical Council]. 2015; (9): 92-9. (in Russian)

8. Brody L.C., et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet. 2002; 71 (5):1207-15.

9. Christensen K.E., et al. The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects. Hum Mutat. 2009; 30 (2): 212-20.

10. Shields D.C., et al. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet. 1999; 64 (4): 1045-55.

11. Fekete K., Berti C., Trovato M., et al. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation. Nutr J. 2012; 11: 75-86.

12. De Wals P., Tairou F., Van Allen M.I., et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007; 357 (2): 135-42.

13. Khoshnood B., Loane M., de Walle H., et al. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ. 2015; 351: h5949.

14. U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 150 (9): 626-31.

15. Castano E., Pinunuri R., Hirsch S., Ronco A.M. Folate and pregnancy, current concepts: it is required folic acid supplementation? Rev Chil Pediatr. 2017; 88 (2): 199-206. doi: 10.4067/S0370-41062017000200001.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)